Kentucky legislature moves to veto session

April 15, 2026

medicaid

Following a flurry of legislative activity, the Kentucky General Assembly has now moved into its Veto Recess, during which Gov. Andy Beshear (D) must either sign into law or veto each of the bills the legislature sent to him. Lawmakers will return on April 14 and 15 for the final two days of the 2026 legislative session to consider overrides of any bills the governor vetoed during the recess.

It’s widely expected that the governor will use his veto pen to strike down several priorities of the Republican-dominated legislature. A couple of health care-related bills await a decision by the governor including HB 2, which would implement some of the Medicaid reform provisions resulting from enactment of the federal One Big Beautiful Bill Act last July. HB 2 would require some recipients to demonstrate community engagement for continued enrollment, and would establish cost-sharing for certain services by Oct. 1, 2028.

The proposal also enhances verification and oversight using multiple state and federal data sources and strengthens fraud prevention in Medicaid waiver programs. Separately, the governor is expected to sign HB 176, which requires insurers to offer programs allowing network providers to qualify for prior authorization exemptions based on performance criteria during evaluation periods.

Initiatives

Calls grow for Drug Patent reform

In a recent blog post, the Pharmaceutical Care Management Association (PCMA) highlighted increased attention to pharmaceutical companies’ abuse of drug patents. Last month, the Supreme Court unanimously ruled in favor of a generic drugmaker in a “skinny labeling” case, a victory for patients. Skinny labels allow generic and biosimilar competitors to launch products for non-patented indications, helping accelerate […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

perspectives

AHIP calls for Bipartisan reform to address health care cost drivers

On July 23, AHIP President and CEO Mike Tuffin wrote an opinion piece in The New York Times saying, “common-sense bipartisan reforms are needed to promote competition in care delivery and prescription drugs, protect consumers from providers and drugmakers’ anticompetitive practices and transition away from the perverse incentives of fee-for-service medicine.” Tuffin notes that health […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

Solutions

PCMA urges preserving patient access and flexibility in new fertility benefits rule

PCMA recently submitted comments to HHS, DOL, and the Treasury (the Departments) in response to the proposed rule establishing a new category of limited excepted benefits for fertility services. PCMA supports the Departments’ goal of expanding access to fertility care while encouraging employer innovation but urged several targeted refinements to ensure the framework is operationally […]
read more >

August 11, 2026

marketplace medicaid

You may also like